间苯三酚应用于无痛胃镜中对食管胃结合部观察效果的影响及安全性

Effect of Phloroglucin on the Observation Effect of Esophagogastric Junction in Painless Gastroscopy and Its Safety Analysis

摘要

目的 分析间苯三酚应用于无痛胃镜中对食管胃结合部观察效果的影响及安全性。方法 选取2022年9月~2023年2月于承德市中心医院行无痛胃镜检查患者,按患者登记号的奇偶性随机分为对照组（无痛胃镜组）135例,观察组（无痛胃镜加用间苯三酚组）115例。观察记录2组患者食管胃结合部观察效果、病变检出率、病变内镜下特征、病理结果、术中术后不良反应发生情况。结果 观察组食管胃结合部易观察率及该部位病变检出率均高于对照组,差别有统计学意义（P=0.038,P=0.035）,观察组非红色调病变检出率高于对照组,差异有统计学意义（P=0.003）。2组病理结果及不良反应发生率比较差别无统计学意义（P>0.05）。结论 无痛胃镜检查前应用间苯三酚,有助于改善食管胃结合部观察效果,从而增加病变检出率,尤其对易漏诊的非红色调病变的检出具有优势,且不良反应较少,安全性较高。

Abstract

Objective To analyze the effect and safety of phloroglucinol on the observation of the esophagogastric junction during painless gastroscopy. Method A control group consisting of 135 cases underwent painless gastroscopy, and an observation group consisting of 115 cases(painless gastroscopy plus phloroglucinol) was randomly formed from patients who underwent painless gastroscopy between September 2022 and February 2023 based on the odd-evenness of their registration numbers. The esophagogastric junction observation effect, lesion detection rate, endoscopic features of lesions, pathological outcomes, and intraoperative and postoperative adverse responses of the two patient groups were noted and monitored. Result This portion of the observation group had a greater observation rate of the esophagogastric junction and a higher rate of lesion detection than the control group, and the difference was statistically significant (P=0.038, P=0.035). In comparison to the control group, the observation group had a greater detection rate of non-red lesions; this difference is statistically significant (P=0.003). Between the two groups, there was no statistically significant difference in the occurrence of adverse responses or pathological results (P>0.05). The difference was statistically significant (P=0.003). The incidence of adverse responses and abnormal outcomes did not change statistically significantly between the two groups (P>0.05). Conclusion The esophagogastric junction's observation impact can be enhanced by applying phloroglucinol before the painless gastroscopy, which will increase the likelihood of lesions being discovered. Finding easily overlooked non-red lesions is one of its specific uses. Additionally, it is more secure and has fewer adverse effects.

关键词

无痛胃镜 / 间苯三酚 / 食管胃结合部 / 观察效果

Key words

painless gastroscopy / phloroglucin / esophagogastric junction / efficacy observation

[1] Wu H, Xin L, Lin JH, et al.Association between sedation and small neoplasm detection during diagnostic esophagogastroduodenoscopy: a propensity score-matched retrospective study[J]. Scandinavian Journal of Gastroenterology, 2022, 57(5): 603-609.
[2] Zhou J, Li Z, Ji R, et al.Influence of Sedation on the Detection Rate of Early Cancer and Precancerous Lesions During Diagnostic Upper Gastrointestinal Endoscopies: A Multicenter Retrospective Study[J]. American Journal of Gastroenterology, 2021, 116(6): 1230-1237.
[3] Lee HJ, Kim B, Kim DW, et al.Does Sedation Affect Examination of Esophagogastric Junction during Upper Endoscopy?[J]. Yonsei Medical Journal, 2015, 56(6): 1566-1571.
[4] Kim ES.Negative impact of sedation on esophagogastric junction evaluation during esophagogastroduodenoscopy[J]. World Journal of Gastroenterology, 2014, 20(18): 5527-5532.
[5] Meining A, Semmler V, Kassem A, et al.The effect of sedation on the quality of upper gastrointestinal endoscopy: an investigator-blinded, randomized study comparing propofol with midazolam[J]. Endoscopy, 2007, 39(4): 345-349.
[6] Chen Z, Liu L, Tu J, et al.Improvement of atropine on esophagogastric junction observation during sedative esophagogastroduodenoscopy[J]. PLOS ONE, 2017, 12(6): e0179490.
[7] Morita A, Nakayama Y, Horiuchi A, et al.Stimulating peristalsis improves esophagogastric junction observation during sedated esophagogastroduodenoscopy in children and adolescents[J]. Acta Gastro Enterologica Belgica, 2022, 85(1): 15-19.
[8] 国家消化系疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟,中华医学会消化病学分会幽门螺杆菌学组,等. 中国胃黏膜癌前状态和癌前病变的处理策略专家共识(2020年)[J]. 中华消化杂志,2020,40(11):731-741.
[9] 国家消化系统疾病临床医学研究中心(上海),中华医学会消化内镜学分会,中国医师协会内镜医师分会消化内镜专业委员会,等. 中国食管鳞癌癌前状态及癌前病变诊治策略专家共识[J]. 中华消化内镜杂志,2020,37(12):853-867.
[10] 赫捷,陈万青,李兆申,等. 中国食管癌筛查与早诊早治指南(2022,北京)[J]. 中华肿瘤杂志,2022,44(6):491-522.
[11] 陈龙奇,胡建昆,季加孚,等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版)[J]. 中华胃肠外科杂志,2018, 21(9):961-975.
[12] 李鹏,王拥军,陈光勇,等. 中国巴雷特食管及其早期腺癌筛查与诊治共识(2017万宁)[J]. 中国实用内科杂志,2017,37(9):798-809.
[13] 刘琳刚. 无痛胃镜与普通胃镜对贲门暴露程度影响及对策研究[D]. 浙江:浙江大学,2016.
[14] 吴会晓,唐旭东,柯俊,等. 无痛胃镜与普通胃镜上消化道疾病检出率分析[J]. 现代消化及介入诊疗,2020,25(10):1359-1363.
[15] Matsuo Y, Yasuda H, Itoh F.Investigation of factors affecting endoscopic observation for esophagogastric junction[J]. Journal of Gastrointestinal Cancer Screening, 2017, 55(5): 640-646.
[16] Jung H, Kim HJ, Choi E, et al.Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.[J]. PloS one, 2021, 16(8): e0255016.
[17] Yun HW, Shim KN, Na SK, et al.Comparison between the Effectiveness of Oral Phloroglucin and Cimetropium Bromide as Premedication for Diagnostic Esophagogastroduodenoscopy: An Open-Label, Randomized, Comparative Study[J]. Clinical Endoscopy, 2015, 48(1): 48.
[18] 熊丽丽,姬劲峰. 间苯三酚对胃镜检查患者的心血管系统的影响分析[J]. 海峡药学,2017,29(2):98-99.
[19] Jung P, Park SB, Kim HW, et al.Cimetropium bromide does not improve polyp and adenoma detection during colonoscope withdrawal[J]. Medicine, 2018, 97(25): e11253.
[20] Kim SY, Park JM, Cho HS, et al.Assessment of Cimetropium Bromide Use for the Detection of Gastric Neoplasms During Esophagogastroduodenoscopy[J]. JAMA Network Open, 2022, 5(3): e223827.
[21] Omata F, Kumakura Y, Ishii N, et al.Noneffectiveness of scopolamine for facilitating detection of upper gastrointestinal neoplasia during screening esophagogastroduodenoscopy: propensity score-matched study[J]. Endoscopy, 2020, 52(7): 556-562.